$189 Million is the total value of Tavio Capital LLC's 11 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 125.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
LH | Buy | LABORATORY CORP AMER HLDGS | $32,914,000 | +6.7% | 195,916 | +9.8% | 17.40% | +39.0% |
MCK | Buy | MCKESSON CORP | $25,351,000 | +25.3% | 185,502 | +23.2% | 13.40% | +63.1% |
HCA | Buy | HCA HEALTHCARE INC | $17,260,000 | +7.9% | 143,333 | +21.1% | 9.12% | +40.5% |
HUM | New | HUMANA INC | $15,822,000 | – | 61,885 | +100.0% | 8.36% | – |
PDCO | Buy | PATTERSON COMPANIES INC | $11,608,000 | -0.6% | 651,397 | +27.7% | 6.14% | +29.4% |
BSX | New | BOSTON SCIENTIFIC CORP | $6,691,000 | – | 164,433 | +100.0% | 3.54% | – |
WMGI | New | WRIGHT MED GROUP N V | $6,676,000 | – | 323,625 | +100.0% | 3.53% | – |
PRAH | New | PRA HEALTH SCIENCES INC | $4,769,000 | – | 48,063 | +100.0% | 2.52% | – |
CI | New | CIGNA CORP NEW | $4,706,000 | – | 31,004 | +100.0% | 2.49% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MOLINA HEALTHCARE INC | 13 | Q2 2020 | 29.6% |
CENTENE CORP DEL | 11 | Q2 2020 | 19.1% |
ANTHEM INC | 10 | Q2 2019 | 22.5% |
BOSTON SCIENTIFIC CORP | 9 | Q4 2019 | 20.9% |
RETROPHIN INC | 9 | Q1 2019 | 3.4% |
ZIMMER BIOMET HOLDINGS INC | 8 | Q2 2020 | 20.6% |
HUMANA INC | 8 | Q4 2019 | 37.8% |
UNIVERSAL HLTH SVCS INC | 8 | Q1 2019 | 14.7% |
HCA HEALTHCARE INC | 8 | Q1 2020 | 12.3% |
MCKESSON CORP | 7 | Q2 2020 | 23.1% |
View Tavio Capital LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2020-10-01 |
13F-HR | 2020-08-13 |
13F-HR | 2020-05-14 |
13F-HR | 2020-02-13 |
13F-HR | 2019-11-13 |
13F-HR | 2019-08-13 |
13F-HR | 2019-05-14 |
13F-HR | 2019-02-14 |
13F-HR | 2018-11-13 |
13F-HR | 2018-08-13 |
View Tavio Capital LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.